Figure 4.
Effects of APAP on hepatic GSH levels and the formation of APAP-protein adducts in WT and Xbp1LKO mice. (A) Hepatic GSH levels were measured at various time points after 500 mg/kg APAP injection. n = 3–6 mice per group. Values represent means ± SEM. (B) Mice were sacrificed at indicated time points after APAP injection. Liver lysates of WT and Xbp1LKO mice (KO) were prepared and pooled for Western blot analysis using anti-APAP, anti-phospho-JNK, and total JNK antibodies. (C) Liver lysates from individual mice treated with APAP for 24 h or left untreated (NT) were subjected to Western blot analysis. Note that the blot was exposed to x-ray film longer than in B to increase the sensitivity.